Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Dermatological Medicine
Volume 2012 (2012), Article ID 401362, 3 pages
http://dx.doi.org/10.1155/2012/401362
Case Report

Dramatic Clinical Response of Relapsed Metastatic Extramammary Paget’s Disease to Trastuzumab Monotherapy

Department of Dermatology, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan

Received 29 November 2011; Accepted 1 February 2012

Academic Editors: M. Curzio and J. Y. Lee

Copyright © 2012 S. Wakabayashi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. J. Slamon, B. Leyland-Jones, S. Shak et al., “Use of chemotherapy plus a monoclonal antibody against her2 for metastatic breast cancer that overexpresses HER2,” The New England Journal of Medicine, vol. 344, no. 11, pp. 783–792, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. K. Inoue, K. Nakagami, M. Mizutani et al., “Randomized phase III trial of trastuzumab monotherapy followed by trastuzumab plus docetaxel versus trastuzumab plus docetaxel as first-line therapy in patients with HER2-positive metastatic breast cancer: the JO17360 Trial Group,” Breast Cancer Research and Treatment, vol. 119, no. 1, pp. 127–136, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. S. Takahagi, H. Noda, A. Kamegashira et al., “Metastatic extramammary Paget's disease treated with paclitaxel and trastuzumab combination chemotherapy,” The Journal of Dermatology, vol. 36, no. 8, pp. 457–461, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. Y. Yagishita and T. Maekawa, “Weekly-docetaxel combination chemotherapy induced CR in advanced extramammary Paget’s disease,” Skin Cancer, vol. 25, no. 3, pp. 367–371, 2010. View at Google Scholar
  5. T. Ogawa, Y. Nagashima, H. Wada et al., “Extramammary Paget's disease: analysis of growth signal pathway from the human epidermal growth factor receptor 2 protein,” Human Pathology, vol. 36, no. 12, pp. 1273–1280, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. M. Takata, A. Fujimoto, H. Aoki, N. Hatta, A. Ooi, and K. Takehara, “erbB-2 overexpression but no activation of β-catenin gene in extramammary Paget's disease,” Journal of Investigative Dermatology, vol. 113, no. 2, pp. 258–262, 1999. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus